Onc Now | Episode 22
In this episode of Onc Now, host Jonathan Sackier is joined by Stephen Freedland, Surgical Oncologist at Cedars-Sinai Medical Center, Los Angeles, California, USA, to discuss the intersections of biology, behaviour, and bias in prostate cancer. From diet and exercise to disparities in outcomes and promising data on enzalutamide, Freedland challenges assumptions and advocates for a more holistic, equitable approach to care.
Apple | Spotify | Amazon Music (37 mins)
Stephen Freedland is the Surgical Lead of the Urological Oncology Disease Research Group at Cedars-Sinai Medical Center and Director of the Center for Integrated Research in Cancer and Lifestyle. His work examines how lifestyle factors such as obesity, exercise, and diet affect prostate cancer risk and progression. He is also a prominent voice in equity-focused cancer care, exploring disparities across racial and gender identity groups, and is a dedicated mentor training the next generation of oncologists.
Timestamps
01:20 – Background and clinical journey
02:39 – Cancer myths: what needs busting
03:22 – Lifestyle’s role in prostate cancer
05:18 – One habit all cancer patients should adopt
06:39 – Yes or No round
10:30 – Diet, obesity, and exercise: the data
13:25 – Mediterranean diet and outcomes
15:30 – Predictive lifestyle factors
16:19 – Racial disparities and root causes
18:35 – Gender-affirming treatment and prostate cancer in trans women
23:20 – Enzalutamide: latest data and developments
25:51 – Broader therapeutic landscape
28:40 – Risk of recurrence
30:19 – Advice for young oncologists
34:00 – Three wishes for the future of prostate cancer care
